Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Biomarkers in multiple sclerosis (a review and experimental data)].
Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4.
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
"Response to the Commentary on "Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin"
Functional impairments in white matter syndrome of neuropsychiatric systemic lupus erythematosus are similar to those observed in patients with multiple sclerosis.
Physical rehabilitation interventions in nonambulatory people with multiple sclerosis: a systematic review.
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity.
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors.
Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
Alemtuzumab in the treatment of multiple sclerosis.
Impact of transcranial direct current stimulation on fatigue in multiple sclerosis.
Dextromethorphan/Quinidine for the treatment of pseudobulbar affect.
Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors in T cell subsets.
Modulation of kallikrein-kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Neuroimaging evidence of deficient axon myelination in Wolfram syndrome.
Reduced Myelin Water in the White Matter Tracts of Patients with Niemann-Pick Disease Type C.
Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.
Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.
Local dynamic stability as a responsive index for the evaluation of rehabilitation effect on fall risk in patients with multiple sclerosis: a longitudinal study.
[Multiple sclerosis].
Cerebrospinal fluid derived immunoglobulin G of different multiple sclerosis patients share mutated sequences in complementarity determining regions.
Cell-Based Reparative Therapies for Multiple Sclerosis.
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)].
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'.
Pages
« first
‹ previous
…
530
531
532
533
534
535
536
537
538
…
next ›
last »